Top intervention news of 2019: ISCHEMIA trials, low-risk TAVR, paclitaxel debate and more

January 18, 2020
Healio and Cardiology Today compiled a list of the most-read cardiac and vascular intervention articles published in 2019. Readers were interested in…

In the JournalsPerspective

Meta-analysis: Paclitaxel-coated balloons may be harmful in below-the-knee lesions

January 15, 2020
A systematic review and study-level meta-analysis of randomized controlled trials of treatment of infrapopliteal arteries found that…

FDA News

FDA designates recall of support catheter as class 1

December 17, 2019
The FDA has designated Cook Medical’s product recall of a support catheter as a class 1 recall, the most serious kind. The recall affects 117…

Meeting News

Top stories from VIVA: Peripheral DES, drug-coated balloons and more

December 1, 2019
Healio and Cardiology Today present meeting highlights from VIVA 19 in Las Vegas. Top stories included the latest from the IMPERIAL head-to-head…

Meeting News

Bioresorbable scaffold effectively treats below-the-knee lesions

November 14, 2019
LAS VEGAS — A bioresorbable scaffold was shown to be safe and effective for treatment of below-the-knee lesions in two studies presented at…

Meeting News

DCB shows durable real-world effectiveness at 4 years

November 12, 2019
LAS VEGAS — In a real-world population with peripheral artery disease, nearly three-quarters of patients treated with a drug-coated balloon…

Meeting News

Ascertainment bias could explain paclitaxel mortality signal

November 11, 2019
LAS VEGAS — It is possible that ascertainment bias and other biases from randomized controlled trials could explain the long-term mortality…

Meeting NewsPerspective

Aspiration mechanical thrombectomy meets safety, efficacy endpoints for acute PE

November 11, 2019
LAS VEGAS — In the EXTRACT-PE trial, an aspiration mechanical thrombectomy device was safe and effective among patients with acute pulmonary…

Meeting News

Sirolimus-coated balloon benefit maintained at 2 years

November 7, 2019
LAS VEGAS — A sirolimus-coated balloon for treatment of peripheral artery disease was associated with positive outcomes at 2 years, according…

Meeting News

Peripheral stent beneficial in common femoral artery stenosis at 2 years

November 6, 2019
LAS VEGAS — A repuncturable vascular mimetic peripheral stent system was safe and effective at 2 years in patients with common femoral artery…

Meeting News

RANGER II SFA: Low-dose paclitaxel-coated balloon superior to PTA at 1 year

November 6, 2019
LAS VEGAS — A low-dose paclitaxel-coated balloon was superior to percutaneous transluminal angioplasty for treatment of femoropopliteal…

Meeting NewsPerspective

IMPERIAL: Peripheral DES similar in patency, different in TLR at 2 years

November 5, 2019
LAS VEGAS — A peripheral drug-eluting stent with a polymer coating conferred lower rates of target lesion revascularization compared with a…

Meeting NewsPerspective

Mortality not different at 5 years in patients treated with DES vs. controls

November 5, 2019
LAS VEGAS — There were no significant differences in mortality at 5 years between patients with peripheral artery disease assigned a…

Meeting News

New advances offer hope to patients with CLI

November 4, 2019
LAS VEGAS — While critical limb ischemia presents many challenges, numerous new technologies and techniques are being developed to help this…

Meeting News

More data needed on prevention of progression from claudication to CLI

November 4, 2019
LAS VEGAS — There has never been a randomized trial to determine what interventions may prevent progression from claudication to critical limb…

Feature

Mortality signal from paclitaxel-coated devices persists, but cause remains elusive

November 1, 2019
SAN FRANCISCO — Analyses continue to show a long-term mortality risk associated with paclitaxel-coated devices in patients with peripheral…

Siemens acquires robotic PCI technology for $1.1 billion

October 29, 2019
Siemens announced it has acquired Corindus Vascular Robotics, manufacturer of robotic-assisted PCI systems, for $1.1 billion. According to a press…

In the JournalsPerspective

Another study finds no evidence of increased long-term mortality with paclitaxel-coated devices

October 9, 2019
Patients who underwent endovascular revascularization with a paclitaxel-based drug-eluting device did not have an increased mortality risk over an…

FDA News

FDA designates recall of guide catheter as class 1

October 8, 2019
The FDA has designated Medtronic’s product recall of a guide catheter as a class 1 recall, the most serious kind. The recall affects 106,298…

Meeting News

AHA: More evidence needed for endovascular therapy for acute PE

October 7, 2019
Interventional devices for treatment of acute pulmonary embolism do not have a high level of evidence, and stakeholders must generate more evidence…